The objectives of this application are to advance understanding of how key genetic interactions involving intestinal and hepatic lipid mobilization also function to modulate the response to injury, inflammation and ER stress as well as regulating elements of liver growth and cancer development. The longstanding focus of this award has been the posttranscriptional regulation of apolipoprotein B (apoB) RNA editing and the apoB isoform-specific (i.e. apoB100 versus apoB48) interaction with microsomal triglyceride transfer protein (Mttp). The BACKGROUND to this proposal is based on the elucidation of new functions and unanticipated roles for the core components of the apoB RNA editing enzyme, namely the RNA binding proteins Apobec-1 and Apobec-1 complementation factor (ACF) and their functional interactions with apoB/Mttp. Our OVERARCHING HYPOTHESIS is that Apobec-1 and ACF are AU-rich RNA binding proteins whose targets, including but not limited to apoB, are regulated in a cell-specific combinatorial manner that in turn modulates important elements of lipid metabolism as well as the response to inflammation and ER stress in the intestine and liver. Our PRELIMINARY DATA demonstrate that Apobec-1-/- mice manifest increased ER stress, an activated unfolded protein response (UPR) and exhibit conditional intestinal lipotoxicity and that both Mttp-IKO and Apobec-1-/- mice demonstrate increased mortality with DSS colitis which is further exacerbated in the double knockout background. Based on these findings, studies in AIM 1 will ask, "How does Apobec-1 interact with Mttp to modulate the response to inflammation and ER stress?" Other work demonstrated that Apobec-1-/- mice exhibit increased gallstone susceptibility when fed a lithogenic diet, a phenotype associated with decreased Cyp7a1 mRNA stability and decreased Cyp7a1 expression. Based on these findings, studies in AIM 2 will ask, "How does Apobec-1 modulate hepatic lipid metabolism and gallstone susceptibility?" Germline deletion of Acf is embryonic lethal and heterozygous Acf mice demonstrate delayed liver regeneration following partial hepatectomy (PH). This growth phenotype is associated with attenuated hepatic IL-6 mRNA induction and decreased IL-6 secretion from Kupffer cells. Despite an attenuated IL-6 response to DEN administration, Acf mice demonstrate a paradoxically increased susceptibility to HCC. Based on these findings, studies in AIM 3 will ask, "How does ACF modulate gene expression to influence liver growth and cancer development? Taken together, these studies will provide continued insight into functional protein-RNA interactions for Apobec-1 and ACF as well as that of Mttp that address their emerging roles beyond lipid metabolism in the regulation of intestinal inflammation, as well as gallstone formation and liver growth.

Public Health Relevance

Innovation and health relevance of this proposal This renewal application will focus on key genetic interactions (Apobec-1/apoB/Mttp) regulating lipid metabolism as well as elements of the UPR and ER stress in intestinal epithelial cells that modify lipotoxic injury and acute experimental colitis. We will use novel murine strains to explore the dialog between Apobec-1/apoB isoform expression and Mttp interactions as well as Apobec-1/ACF/miRNA interactions that modulate gallstone development and, finally, to understand how ACF/RNA/miRNA interactions modify features of liver growth and cancer development. These studies will expand understanding of the key genetic players involved in tissue-specific regulation of lipid mobilization in the liver and small intestine and provide crucial information linking metabolic pathways that modulate ER stress and inflammation with growth and cancer development.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL038180-28
Application #
8461685
Study Section
Special Emphasis Panel (ZRG1-DKUS-B (04))
Program Officer
Liu, Lijuan
Project Start
1986-07-01
Project End
2014-04-30
Budget Start
2013-05-01
Budget End
2014-04-30
Support Year
28
Fiscal Year
2013
Total Cost
$546,093
Indirect Cost
$186,821
Name
Washington University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Xie, Yan; Fung, Ho Yee Joyce; Newberry, Elizabeth P et al. (2014) Hepatic Mttp deletion reverses gallstone susceptibility in L-Fabp knockout mice. J Lipid Res 55:540-8
Olszak, Torsten; Neves, Joana F; Dowds, C Marie et al. (2014) Protective mucosal immunity mediated by epithelial CD1d and IL-10. Nature 509:497-502
Ong, Kuok Teong; Mashek, Mara T; Davidson, Nicholas O et al. (2014) Hepatic ATGL mediates PPAR-? signaling and fatty acid channeling through an L-FABP independent mechanism. J Lipid Res 55:808-15
Liang, Zhe; Xie, Yan; Dominguez, Jessica A et al. (2014) Intestine-specific deletion of microsomal triglyceride transfer protein increases mortality in aged mice. PLoS One 9:e101828
de Vries, Simone; Jeffe, Donna B; Pruitt, Sandi L et al. (2014) Patient, hospital, and geographic disparities associated with comanagement during hospitalization for colorectal cancer surgery. J Hosp Med 9:226-31
Schootman, M; Lian, M; Pruitt, S L et al. (2014) Hospital and geographic variability in two colorectal cancer surgery outcomes: complications and mortality after complications. Ann Surg Oncol 21:2659-66
Schootman, Mario; Lian, Min; Pruitt, Sandi L et al. (2014) Hospital and geographic variability in thirty-day all-cause mortality following colorectal cancer surgery. Health Serv Res 49:1145-64
Kushnir, Vladimir M; Nalbantoglu, Ilke; Watson, Rao et al. (2014) Advanced colorectal adenomas in patients under 45 years of age are mostly sporadic. Dig Dis Sci 59:2757-64
Bose, Sandip K; Kim, Hangeun; Meyer, Keith et al. (2014) Forkhead box transcription factor regulation and lipid accumulation by hepatitis C virus. J Virol 88:4195-203
Barrett, Bradley S; Guo, Kejun; Harper, Michael S et al. (2014) Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo. Virology 468-470:601-8

Showing the most recent 10 out of 124 publications